These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27658790)

  • 1. Design, synthesis, and biological characterization of novel PEG-linked dimeric modulators for CXCR4.
    Yang Y; Gao M; Zhang Q; Zhang C; Yang X; Huang Z; An J
    Bioorg Med Chem; 2016 Nov; 24(21):5393-5399. PubMed ID: 27658790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Bivalent and D-Peptide Ligands of CXCR4 Mobilize Hematopoietic Progenitor Cells to the Blood in C3H/HeJ Mice.
    Mao Y; Meng Q; Song P; Zhu S; Xu Y; Snyder EY; An J; Huang Z
    Cell Transplant; 2018 Aug; 27(8):1249-1255. PubMed ID: 29991278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and evaluation of a CXCR4 targeting peptide 4DV3 as an HIV entry inhibitor and a ligand for targeted drug delivery.
    Heon Lee I; Palombo MS; Zhang X; Szekely Z; Sinko PJ
    Eur J Pharm Biopharm; 2019 May; 138():11-22. PubMed ID: 29894816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel synthetic bivalent ligand to probe chemokine receptor CXCR4 dimerization and inhibit HIV-1 entry.
    Choi WT; Kumar S; Madani N; Han X; Tian S; Dong CZ; Liu D; Duggineni S; Yuan J; Sodroski JG; Huang Z; An J
    Biochemistry; 2012 Sep; 51(36):7078-86. PubMed ID: 22897429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of CXCR4 ligands.
    Mona CE; Besserer-Offroy É; Cabana J; Leduc R; Lavigne P; Heveker N; Marsault É; Escher E
    Org Biomol Chem; 2016 Nov; 14(43):10298-10311. PubMed ID: 27752700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists.
    Mishra RK; Shum AK; Platanias LC; Miller RJ; Schiltz GE
    Sci Rep; 2016 Jul; 6():30155. PubMed ID: 27456816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, and Characterization of Novel CXCR4 Antagonists Featuring Cyclic Amines.
    Lin Y; Li Z; Ma H; Wang Y; Wang X; Song S; Zhao L; Wu S; Tian S; Fu C; Luo L; Zhu F; He S; Zheng J; Zhang X
    ChemMedChem; 2020 Jul; 15(13):1150-1162. PubMed ID: 32391652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of low molecular weight CXCR4 ligands.
    Sakyiamah MM; Kobayakawa T; Fujino M; Konno M; Narumi T; Tanaka T; Nomura W; Yamamoto N; Murakami T; Tamamura H
    Bioorg Med Chem; 2019 Mar; 27(6):1130-1138. PubMed ID: 30772128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity CXCR4 inhibitors generated by linking low affinity peptides.
    Zhang C; Huang LS; Zhu R; Meng Q; Zhu S; Xu Y; Zhang H; Fang X; Zhang X; Zhou J; Schooley RT; Yang X; Huang Z; An J
    Eur J Med Chem; 2019 Jun; 172():174-185. PubMed ID: 30978562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and evaluation of novel CXCR4 antagonists based on an aminoquinoline template.
    Lin Y; Li Z; Xu C; Xia K; Wu S; Hao Y; Yang Q; Ma H; Zheng J; Luo L; Zhu F; He S; Zhang X
    Bioorg Chem; 2020 Jun; 99():103824. PubMed ID: 32334192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and structure-activity-relationship of a novel series of CXCR4 antagonists.
    Li Z; Wang Y; Fu C; Wang X; Wang JJ; Zhang Y; Zhou D; Zhao Y; Luo L; Ma H; Lu W; Zheng J; Zhang X
    Eur J Med Chem; 2018 Apr; 149():30-44. PubMed ID: 29494843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of 2,5-diamino and 2,5-dianilinomethyl pyridine analogues as potential CXCR4 antagonists.
    Virani S; Liang Z; Yoon Y; Shim H; Mooring SR
    Bioorg Med Chem Lett; 2019 Jan; 29(2):220-224. PubMed ID: 30514601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bivalent 14-mer peptide ligands of CXCR4 with polyproline linkers with anti-chemotactic activity against Jurkat cells.
    Tanaka T; Aoki T; Nomura W; Tamamura H
    J Pept Sci; 2017 Jul; 23(7-8):574-580. PubMed ID: 28078743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach.
    Ueda S; Kato M; Inuki S; Ohno H; Evans B; Wang ZX; Peiper SC; Izumi K; Kodama E; Matsuoka M; Nagasawa H; Oishi S; Fujii N
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4124-9. PubMed ID: 18539453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting SDF-1/CXCL12 with a ligand that prevents activation of CXCR4 through structure-based drug design.
    Veldkamp CT; Ziarek JJ; Peterson FC; Chen Y; Volkman BF
    J Am Chem Soc; 2010 Jun; 132(21):7242-3. PubMed ID: 20459090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists.
    Våbenø J; Haug BE; Rosenkilde MM
    Future Med Chem; 2015; 7(10):1261-83. PubMed ID: 26144264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studying the binding interactions of allosteric agonists and antagonists of the CXCR4 receptor.
    Planesas JM; Pérez-Nueno VI; Borrell JI; Teixidó J
    J Mol Graph Model; 2015 Jul; 60():1-14. PubMed ID: 26080355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Activity Relationship and Signaling of New Chimeric CXCR4 Agonists.
    Mona CE; Besserer-Offroy É; Cabana J; Lefrançois M; Boulais PE; Lefebvre MR; Leduc R; Lavigne P; Heveker N; Marsault É; Escher E
    J Med Chem; 2016 Aug; 59(16):7512-24. PubMed ID: 27434274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and mutational analyses of CXCR4-antagonist interactions and design of new antagonistic analogs.
    Meng Q; Zhu R; Mao Y; Zhu S; Wu Y; Huang LSM; Ciechanover A; An J; Xu Y; Huang Z
    Biosci Rep; 2023 Dec; 43(12):. PubMed ID: 38131305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic bivalent ligand of CXCR4 inhibits HIV infection.
    Xu Y; Duggineni S; Espitia S; Richman DD; An J; Huang Z
    Biochem Biophys Res Commun; 2013 Jun; 435(4):646-50. PubMed ID: 23688427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.